Target intelligence / Profile preview

Polyunsaturated fatty acid bis-allylic position (PUFA bis-allylic position)

Target
PUFA bis-allylic position
Molecular classification
Other (structural motif within fatty acids)
01

Overview

The bis-allylic position in polyunsaturated fatty acids is a chemically reactive site located between two double bonds in the fatty acid backbone. Hydrogens at these positions are particularly susceptible to abstraction by reactive oxygen species (ROS) or enzymes such as lipoxygenases, initiating lipid peroxidation chain reactions. These events are central to processes like ferroptosis, oxidative stress-induced cell death, and the production of lipid signaling molecules. Replacement of bis-allylic hydrogens with deuterium (D-PUFA) strengthens the bond, rendering these sites more resistant to ROS attack, and has been shown experimentally to protect cells and organisms against lipid peroxidation-driven diseases. However, the bis-allylic position is not a molecular target in the conventional sense (e.g., not a receptor, enzyme, or protein), but rather a vulnerable structural aspect of certain fatty acids critical in cell biology and disease pathogenesis.

Other names
bis-allylic position of PUFAbis-allylic hydrogen in polyunsaturated fatty acidsPUFA bis-allylic site
02

Mechanism of action

Deuteration at the bis-allylic position slows the rate of hydrogen abstraction and suppresses lipid peroxidation, conferring cellular protection from ferroptosis and oxidative stress

03

Biological functions

Lipid peroxidation hotspotDeterminant of susceptibility to oxidative damageROS (reactive oxygen species) reactivityInitiator of autoxidation reactions
04

Disease associations

Neurodegenerative disease (via oxidative damage)Cardiovascular disease (via lipid peroxidation)Possibly inflammation and retinal diseases such as age-related macular degeneration
05

Safety considerations

Not applicable (site within a molecule, not a therapeutic target). For deuterated PUFAs, concerns may relate to altered metabolism or long-term systemic effects, but these are experimental and not firmly established.
06

Interacting drugs

No direct drugs; however, deuterated polyunsaturated fatty acids (D-PUFAs) are under investigation as experimental therapeutics that modify these positions to resist oxidative attack
07

Biomarkers

No standard clinical biomarkers; lipid peroxidation end-products (e.g., lipid hydroperoxides, Neuroprostanes from DHA) used in research as indirect biomarkers of oxidative activity at bis-allylic sites

Beyond the preview

Go deeper on Polyunsaturated fatty acid bis-allylic position (PUFA bis-allylic position).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polyunsaturated fatty acid bis-allylic position (PUFA bis-allylic position).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call